Search Results - "McGrail, Kieran"

  • Showing 1 - 19 results of 19
Refine Results
  1. 1

    Proteoliposome-based full-length ZnT8 self-antigen for type 1 diabetes diagnosis on a plasmonic platform by Wan, Hao, Merriman, Chengfeng, Atkinson, Mark A., Wasserfall, Clive H., Mcgrail, Kieran M., Liang, Yongye, Fu, Dax, Dai, Hongjie

    “…Identified as a major biomarker for type 1 diabetes (T1D) diagnosis, zinc transporter 8 autoantibody (ZnT8A) has shown promise for staging disease risk and…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Peripheral immune circadian variation, synchronisation and possible dysrhythmia in established type 1 diabetes by Beam, Craig A., Beli, Eleni, Wasserfall, Clive H., Woerner, Stephanie E., Legge, Megan T., Evans-Molina, Carmella, McGrail, Kieran M., Silk, Ryan, Grant, Maria B., Atkinson, Mark A., DiMeglio, Linda A.

    Published in Diabetologia (01-08-2021)
    “…Aims/hypothesis The circadian clock influences both diabetes and immunity. Our goal in this study was to characterise more thoroughly the circadian patterns of…”
    Get full text
    Journal Article
  4. 4
  5. 5

    1729-P: Circadian Patterns of Autoimmune Components in the Blood of Persons with Type 1 Diabetes: Implications for the Timing of Blood Sampling by BELI, ELENI, DIMEGLIO, LINDA, WOERNER, STEPHANIE, EVANS-MOLINA, CARMELLA, MCGRAIL, KIERAN M., WASSERFALL, CLIVE, ATKINSON, MARK A., BEAM, CRAIG

    Published in Diabetes (New York, N.Y.) (01-06-2019)
    “…Purpose: Immune populations and cytokines are known to exhibit distinct circadian ("daily") variations. We sought to characterize circadian-related immune…”
    Get full text
    Journal Article
  6. 6

    No Alterations in the Frequency of FOXP3+ Regulatory T-Cells in Type 1 Diabetes by BRUSKO, Todd, WASSERFALL, Clive, ATKINSON, Mark, MCGRAIL, Kieran, SCHATZ, Richard, LEE VIENER, Hilla, SCHATZ, Desmond, HALLER, Michael, ROCKELL, Jennifer, GOTTLIEB, Peter, CLARE-SALZLER, Michael

    Published in Diabetes (New York, N.Y.) (01-03-2007)
    “…No Alterations in the Frequency of FOXP3 + Regulatory T-Cells in Type 1 Diabetes Todd Brusko 1 , Clive Wasserfall 1 , Kieran McGrail 1 , Richard Schatz 1 ,…”
    Get full text
    Journal Article
  7. 7

    Autologous Umbilical Cord Blood Transfusion in Very Young Children With Type 1 Diabetes by Haller, Michael J, Wasserfall, Clive H, McGrail, Kieran M, Cintron, Miriam, Brusko, Todd M, Wingard, John R, Kelly, Susan S, Shuster, Jonathan J, Atkinson, Mark A, Schatz, Desmond A

    Published in Diabetes care (01-11-2009)
    “…OBJECTIVE: Interest continues to grow regarding the therapeutic potential for umbilical cord blood therapies to modulate autoimmune disease. We conducted an…”
    Get full text
    Journal Article
  8. 8

    Autologous Umbilical Cord Blood Transfusion in Young Children With Type 1 Diabetes Fails to Preserve C-Peptide by Haller, Michael J, Wasserfall, Clive H, Hulme, Maigan A, Cintron, Miriam, Brusko, Todd M, McGrail, Kieran M, Sumrall, Theresa M, Wingard, John R, Theriaque, Douglas W, Shuster, Jonathan J, Atkinson, Mark A, Schatz, Desmond A

    Published in Diabetes care (01-12-2011)
    “…OBJECTIVE: We conducted an open-label, phase I study using autologous umbilical cord blood (UCB) infusion to ameliorate type 1 diabetes (T1D). Having…”
    Get full text
    Journal Article
  9. 9

    339 A serum exocrine enzyme as a biomarker of response to immunotherapy in type 1 diabetes by Bruggeman, Brittany S, McGrail, Kieran, Gonzalez, Nicole, Wasserfall, Clive, Campbell-Thompson, Martha, Atkinson, Mark, Haller, Michael, Schatz, Desmond

    “…OBJECTIVES/GOALS: We assessed the relationship between C-peptide preservation and a serum exocrine pancreatic enzyme (trypsin) in a recently concluded clinical…”
    Get full text
    Journal Article
  10. 10
  11. 11

    1623-P: Artificial Intelligence with QuPATH in Pancreatic Cell Classification by Guyot, Michael, Williams, MacKenzie D, Bumgarner, Benjamin M, McGrail, Kieran M, Campbell-Thompson, Martha, Haller, Michael J, Bruggeman, Brittany S

    Published in Diabetes (New York, N.Y.) (01-06-2024)
    “…We developed Artificial Intelligence classification algorithms in QuPATH containing both supervised and unsupervised components to quantify and classify the…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Exocrine Pancreatic Enzymes Are a Serological Biomarker for Type 1 Diabetes Staging and Pancreas Size by Ross, James J, Wasserfall, Clive H, Bacher, Rhonda, Perry, Daniel J, McGrail, Kieran, Posgai, Amanda L, Dong, Xiaoru, Muir, Andrew, Li, Xia, Campbell-Thompson, Martha, Brusko, Todd M, Schatz, Desmond A, Haller, Michael J, Atkinson, Mark A

    Published in Diabetes (New York, N.Y.) (01-04-2021)
    “…Exocrine pancreas abnormalities are increasingly recognized as features of type 1 diabetes. We previously reported reduced serum trypsinogen levels and in a…”
    Get full text
    Journal Article
  14. 14

    Serum Trypsinogen Levels in Type 1 Diabetes by Li, Xia, Campbell-Thompson, Martha, Wasserfall, Clive H, McGrail, Kieran, Posgai, Amanda, Schultz, Andrew R, Brusko, Todd M, Shuster, Jonathan, Liang, Faming, Muir, Andrew, Schatz, Desmond, Haller, Michael J, Atkinson, Mark A

    Published in Diabetes care (01-04-2017)
    “…The pancreas in type 1 diabetes exhibits decreased size (weight/volume) and abnormal exocrine morphology. Serum trypsinogen levels are an established marker of…”
    Get full text
    Journal Article
  15. 15

    Exocrine Pancreatic Function as a Novel Biomarker in Pre-T1D by ROSS, JAMES J., WASSERFALL, CLIVE, PERRY, DANIEL J., MCGRAIL, KIERAN M., POSGAI, AMANDA L., BRUSKO, TODD M., SCHATZ, DESMOND, HALLER, MICHAEL J., ATKINSON, MARK A.

    Published in Diabetes (New York, N.Y.) (01-07-2018)
    “…Recent studies demonstrated reduced serum trypsinogen levels as well as pancreatic weight/volume in patients with type 1 diabetes (T1D) and…”
    Get full text
    Journal Article
  16. 16

    Exendin-4 Therapy in NOD Mice with New-Onset Diabetes Increases Regulatory T Cell Frequency by Xue, Song, Wasserfall, Clive H., Parker, Matthew, Brusko, Todd M., McGrail, Sean, McGrail, Kieran, Moore, Marcus, Campbell-Thompson, Martha, Schatz, Desmond A., Atkinson, Mark A., Haller, Michael J.

    Published in Annals of the New York Academy of Sciences (01-12-2008)
    “…Recent studies, albeit controversial, have suggested that the incretin exendin‐4 (Ex‐4) is capable of inducing β cell proliferation in vivo. Furthermore, this…”
    Get full text
    Journal Article
  17. 17

    No Alterations in the Frequency of FOXP3^sup +^ Regulatory T-Cells in Type 1 Diabetes by Brusko, Todd, Wasserfall, Clive, McGrail, Kieran, Schatz, Richard

    Published in Diabetes (New York, N.Y.) (01-03-2007)
    “…Regulatory T-cells (Tregs) play a critical role in maintaining dominant peripheral tolerance. Previous characterizations of Tregs in type 1 diabetes have used…”
    Get full text
    Journal Article
  18. 18

    No Alterations in the Frequency of FOXP3 super(+) Regulatory T-Cells in Type 1 Diabetes by Brusko, Todd, Wasserfall, Clive, McGrail, Kieran, Schatz, Richard, Viener, Hilla Lee, Schatz, Desmond, Haller, Michael, Rockell, Jennifer, Gottlieb, Peter, Clare-Salzler, Michael, Atkinson, Mark

    Published in Diabetes (New York, N.Y.) (01-03-2007)
    “…Regulatory T-cells (Tregs) play a critical role in maintaining dominant peripheral tolerance. Previous characterizations of Tregs in type 1 diabetes have used…”
    Get full text
    Journal Article
  19. 19

    No alterations in the frequency of FOXP[3.sup.+] regulatory T-cells in type 1 diabetes by Brusko, Todd, Wasserfall, Clive, McGrail, Kieran, Schatz, Richard, Viener, Hilla Lee, Schatz, Desmond, Haller, Michael, Rockell, Jennifer, Gottlieb, Peter, Clare-Salzler, Michael, Atkinson, Mark

    Published in Diabetes (New York, N.Y.) (01-03-2007)
    “…Regulatory T-cells (Tregs) play a critical role in maintaining dominant peripheral tolerance. Previous characterizations of Tregs in type 1 diabetes have used…”
    Get full text
    Journal Article